Related Experiment Video
Updated: Apr 20, 2026
07:10
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
23.6K
Primary prophylaxis of variceal bleeding
Jawad A Ilyas1, Fasiha Kanwal2
1Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, 6620 Main St., Houston, TX 77030, USA.
Gastroenterology Clinics of North America
|December 3, 2014
Summary
Gastroesophageal varices affect many cirrhosis patients. Timely screening and effective therapies like beta-blockers or endoscopic variceal ligation are crucial for preventing bleeding and improving patient outcomes.
Area of Science:
- Hepatology
- Gastroenterology
- Clinical Medicine
Background:
- Gastroesophageal varices are common in cirrhosis patients, affecting nearly half at diagnosis.
- Variceal bleeding is a significant complication, occurring in 25-35% of cirrhosis cases.
Purpose of the Study:
- To highlight the importance of timely screening for gastroesophageal varices.
- To emphasize the need for effective primary prophylaxis strategies to prevent variceal bleeding.
Main Methods:
- Review of clinical studies on variceal bleeding prevention.
- Analysis of therapeutic options including beta-blockers and endoscopic variceal ligation.
Main Results:
- Beta-blockers and endoscopic variceal ligation are proven effective in preventing a first variceal bleeding episode.
- Successful prevention hinges on timely patient screening and therapy selection.
Conclusions:
- Proactive management of gastroesophageal varices is essential in cirrhosis care.
- Optimizing patient compliance and therapeutic effectiveness is key to successful primary prophylaxis.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
832
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
832
01:24Esophageal Varices-I: Introduction
2.4K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
2.4K
01:29Venous Thrombosis III: Interprofessional Care
477
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
477
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.7K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
307
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
307
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K